|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: RadiopharmacyRadiopharmacy Posters |
1 Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China
1317
Objectives: To date, the main strategy for developing new imaging probes has focused on research into plaque-binding ThT and CR derivatives. So, design of radiotracers with novel core structures to image Aβ in vivo will be a challenge. 4,5-Dianilinophthalimide (DAPH), with its ability to inhibit and reverse β-sheet containing fibrils, is believed to bind the Aβ fibrils and plaques. This prompted us to apply it as a promising candidate of novel core structure for Aβ imaging agents. Here we report the synthesis and evaluation of DAPH derivative as a potential ligand for Aβ plaques.
Methods: Novel radioiodinated DAPH derivative of [I-125]-4-iodoanilinophthalimide was achieved by an iododestannylation reaction. The tributyltin derivative was prepared by tributyltin exchange reaction from its bromide precursor, which was obtained from phthalimide by N-methylation, nitration, reduction with stannous chloride, and coupling with 1-bromo-4-iodobenzene. HPLC-purified [I-125] ligand showed radiochemical purity >98% with a theoretical specific activity (~2000 Ci/mmol). Its binding to post mortem human AD brain homogenates was measured.
Results: [I-125] ligand displayed excellent binding affinity for human AD brain homogenates in vitro with Kd= 0.21±0.08nM.
Conclusions: This result demonstrates that DAPH derivative has high binding affinity for Aβ aggregates. Preparation and in vivo evaluation of [C-11]labelled DAPH derivatives are currently underway.
Research Support: 1. Funded by NSFC (20471011). 2. Thanks to Radiopharmeceutical Center, Institute of Applied Physics, Shanghai, China.
| ||||||||||||||||||||||||||||||||||||||